Merck & Co

ISIN US58933Y1055

WKN A0YD8Q

Market cap (in EUR)

188.605,05 Mio.

Country

USA

Sector

Gesundheitswesen

Dividend yield

3,71%

Overview

Quote

GBP 63.33

02/05/2025 (gettex)

-0.40|-0.63%

daily change

52 weeks low/high

57.71

104.81

Description

Merck & Co. Inc. ist ein forschungsorientiertes, globales Pharmaunternehmen, das ein breites Sortiment an neuartigen Medikamenten, Impfstoffen und biologischen Therapeutika erforscht, entwickelt, produziert und vermarktet. Das Angebot richtet sich vorwiegend an Krankenhäuser, Apotheken, Einzelhändler, Versicherungen, Regierungsverwaltungen oder institutionelle Einrichtungen aus dem Gesundheitswesen. Des Weiteren bietet Merck & Co. nicht-verschreibungspflichtige Medikamente, Produkte für die Fußpflege und Sonnenschutzmittel sowie Gesundheitsprodukte für Tiere an. Dabei bedient sich das Unternehmen der Biotechnologie, der Genforschung und der Gentherapie. Schwerpunkte sind die Behandlung von Allergien, Atemwegserkrankungen, Infektionskrankheiten, Krebs, Herz- und Kreislauferkrankungen, Erkrankungen des zentralen Nervensystems sowie Hautkrankheiten. Die Aktivitäten des Unternehmens gliedern sich in die Geschäftsbereiche Pharmaceuticals, Animal Health, Healthcare Services und Alliances. Das Segment Merck Pharmaceutical vermarktet verschreibungspflichtige therapeutische und vorbeugende Produkte aus dem medizinischen Bereich. Diese enthalten Wirkstoffe gegen Arteriosklerose (Arterienverkalkung), Herz-Rhythmus-Störungen, Osteoporose (Knochengewebeschwund) und Asthma. Außerdem werden Impfstoffe (Recombivax HB, Varivax), Schmerzmittel (Vioxx), Augenheilmittel, Hemmstoffe bei AIDS-Infektionen (Crixivan) oder Mittel gegen Eiterbildung (Pepcid) angeboten. In dem Geschäftsbereich Animal Health konzentriert sich Merck auf die Erforschung, Herstellung und den Vertrieb von Impfstoffen, Antiinfektiva und antiparasitäre Medikamente für Nutztiere und Aquaris Das Segment Healthcare Services bietet Dienstleistungen und Lösungen, die sich auf Engagement, Gesundheitsanalytik und klinische Dienstleistungen zur Verbesserung der Pflege an Patienten konzentriert. Der Bereich Alliances umfasst die Forschungs- und Entwicklungspartnerschaft AstraZeneca LP für den Vertrieb der Medikamente Nexium und Prilosec. Der Hauptsitz von Merck & Co. Inc. befindet sich in Kenilworth, New Jersey.
Quelle: Facunda financial data GmbH

Show more Show less

Gesundheitswesen Biopharmazeutische Produkte Andere Biopharmazeutika USA

Chart

30/04/2024 - 30/04/2025

Add ETF for comparison

Show more chart settings

Financials

Key metrics

Market capitalisation, EUR	188.605,05 Mio.
EPS, EUR	6,40
P/B ratio	4,65
P/E ratio	12,40
Dividend yield	3,71%

Income statement (2024)

Revenue, EUR	59.141,43 Mio.
Net income, EUR	15.824,24 Mio.
Profit margin	26,76%

Learn more

What ETF is Merck & Co in?

There are 417 ETFs which contain Merck & Co. All of these ETFs are listed in the table below. The ETF with the largest weighting of Merck & Co is the SPDR S&P U.S. Health Care Select Sector UCITS ETF USD.

Show entries

Search:

ETF	Weight	Investment focus	Fund size (in m EUR)
SPDR S&P U.S. Health Care Select Sector UCITS ETF USD	4.30%	Equity United States Health Care	306
iShares S&P 500 Health Care Sector UCITS ETF (Acc)	4.25%	Equity United States Health Care	2,046
iShares S&P 500 Health Care Sector UCITS ETF EUR Hedged (Dist)	4.25%	Equity United States Health Care	90
Xtrackers MSCI USA Health Care UCITS ETF 1D	4.13%	Equity United States Health Care	552
Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C	3.77%	Equity World Health Care Social/Environmental	31
Invesco S&P World Health Care ESG UCITS ETF Acc	3.70%	Equity World Health Care Social/Environmental	91
WisdomTree US Equity Income UCITS ETF Acc	3.37%	Equity United States Dividend	73
WisdomTree US Equity Income UCITS ETF EUR Hedged Acc	3.37%	Equity United States Dividend	1
WisdomTree US Equity Income UCITS ETF GBP Hedged Acc	3.37%	Equity United States Dividend	1
WisdomTree US Equity Income UCITS ETF	3.37%	Equity United States Dividend	37

Showing 1 to 10 of 417 entries

1 2 3 4 5…42

Savings plan offers

Here you can find information about the savings plan availability for the stock. You can use the table to compare savings plan offers for the selected savings rate.

Source: justETF Research; As of 5/2025; *Affiliate link
— The offers are sorted in the following way: 1. Rating 2. Execution fee 3. Number of stock savings plans. The number of stock savings plans is rounded.
— No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.

Performance

Returns overview

YTD	-19.41%
1 month	-8.28%
3 months	-20.08%
6 months	-19.64%
1 year	-38.38%
3 years	-9.58%
5 years	+1.29%
Since inception (MAX)	+54.99%
2024	-7.57%
2023	-7.60%
2022	+61.86%
2021	-4.59%

Monthly returns in a heat map

Risk

Risk metrics in this section:

Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.

ETF returns include dividend payments (if applicable).